| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/22/2009 | CA2303973C Prolonged release formulation of carbamazepine |
| 12/22/2009 | CA2276283C Composition with release-controlling action |
| 12/22/2009 | CA2276267C Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 12/22/2009 | CA2205022C Adjuvant for a vaccine composition |
| 12/22/2009 | CA2188387C Hard candy with tooth plaque-neutralizing effect |
| 12/22/2009 | CA2185802C Hydrophobic drug delivery systems |
| 12/20/2009 | CA2637538A1 Dar 1 (dermal acne remover) |
| 12/17/2009 | WO2009152458A1 Liquid formulation suitable for infusion comprising an adenosine receptor antagonist for treating heart failure and renal insufficiency. |
| 12/17/2009 | WO2009152369A1 Pharmaceutical formulation of ketorolac for intranasal administration |
| 12/17/2009 | WO2009152222A2 Fluid bed meal containing a marker and methods of making |
| 12/17/2009 | WO2009152167A2 Delivery of therapeutics |
| 12/17/2009 | WO2009152144A2 All day rhinitic condition treatment regimen |
| 12/17/2009 | WO2009152070A2 Intradialytic administration of sodium thiosulfate |
| 12/17/2009 | WO2009152041A2 Controlled release formulations of pramipexole |
| 12/17/2009 | WO2009151977A1 Biodegradable impact-modified polymer compositions |
| 12/17/2009 | WO2009151974A1 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
| 12/17/2009 | WO2009151574A1 Hot melt extruded film containing silicon dioxide |
| 12/17/2009 | WO2009151498A2 Memantine formulations |
| 12/17/2009 | WO2009151394A1 Sublingual compositions comprising (2s) - (4e) -n-methyl-5- (3- (5-isopropoxypyridin) yl) -4-penten-2-amine |
| 12/17/2009 | WO2009151295A2 Pharmaceutical formulation comprising azelnidipine and hmg-coa reductase inhibitor or angiotensin ii receptor blocker |
| 12/17/2009 | WO2009151090A1 Rapidly disintegrating preparation containing calcium carbonate |
| 12/17/2009 | WO2009151072A1 Tablet quickly disintegrating in the oral cavity and method for producing the same |
| 12/17/2009 | WO2009150883A1 Skin-substitutive membrane, metal mold, and method of evaluating agent for external application onto skin |
| 12/17/2009 | WO2009150686A1 Liposomes capable of effectively binding the beta amyloid peptide |
| 12/17/2009 | WO2009150665A1 Orally disintegrating pharmaceutical compositions of escitalopram and salts thereof |
| 12/17/2009 | WO2009150630A2 Process for preparing a carbapenem antibiotic composition |
| 12/17/2009 | WO2009150530A2 Novel foam composition |
| 12/17/2009 | WO2009150514A1 Process for making gastroretentive dosage forms |
| 12/17/2009 | WO2009150408A2 Topical antimuscarinic formulations |
| 12/17/2009 | WO2009150371A2 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors |
| 12/17/2009 | WO2009150324A1 Magnesium system and use thereof in the cosmetics industry |
| 12/17/2009 | WO2009150323A1 Use of a matrix for orally administering sustained release magnesium, and composition containing said matrix |
| 12/17/2009 | WO2009150278A1 Pharmaceutical composition of melphalan |
| 12/17/2009 | WO2009150257A2 Compositions for treating rosacea |
| 12/17/2009 | WO2009150238A2 Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives |
| 12/17/2009 | WO2009150228A2 Pharmaceutical formulations |
| 12/17/2009 | WO2009150209A1 In situ gelling systems as sustained delivery for front of eye |
| 12/17/2009 | WO2009150136A1 Novel embedment particles for inhalation |
| 12/17/2009 | WO2009150120A1 New emulsions for producing medicinal products |
| 12/17/2009 | WO2009149955A2 Method for the selection of a suitable adjuvant for the production of solid dispersions for pharmaceutical formulations |
| 12/17/2009 | WO2009149599A1 Liposome medicament and preparation method and use thereof |
| 12/17/2009 | WO2009149553A1 Modified protein excipient for delayed-release tablet |
| 12/17/2009 | WO2009149537A1 Injectable polymer-lipid blend |
| 12/17/2009 | WO2009132225A3 Rehydratable polysaccharide particles and sponge |
| 12/17/2009 | WO2009131752A3 Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration |
| 12/17/2009 | WO2009117410A3 Formation of nanostructured particles of poorly water soluble drugs and recovery by mechanical techniques |
| 12/17/2009 | WO2009106714A3 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock animals |
| 12/17/2009 | WO2009092810A3 Single pharmaceutical composition containing antibiotics and probiotics |
| 12/17/2009 | WO2009027644A3 Compositions for the treatment of neoplastic diseases |
| 12/17/2009 | WO2009022308A3 Spray-drying process for the manufacture of dye-loaded particles |
| 12/17/2009 | WO2009022307A3 Dye-loaded particles |
| 12/17/2009 | WO2009010238A3 Duloxetine formulations |
| 12/17/2009 | WO2008117125A3 Compositions capable of facilitating penetration across a biological barrier |
| 12/17/2009 | US20090312706 Transdermal local anesthetic patch with injection port |
| 12/17/2009 | US20090312690 Selective peripheral nerve plexus implantable infusion device and method |
| 12/17/2009 | US20090312524 Compositions and methods comprising collagen |
| 12/17/2009 | US20090312441 Organic compounds |
| 12/17/2009 | US20090312440 Agent for improving tissue penetration |
| 12/17/2009 | US20090312390 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 12/17/2009 | US20090311406 Products containing smart foam and method of making |
| 12/17/2009 | US20090311337 Biodegradable particle and method for producing the same |
| 12/17/2009 | US20090311336 Particle containing ultraviolet absorber |
| 12/17/2009 | US20090311335 Combination of a triptan and an nsaid |
| 12/17/2009 | US20090311334 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 12/17/2009 | US20090311333 Feed or food product composition |
| 12/17/2009 | US20090311332 Method for forming mesoporous silica nanoparticles, mesoporous silica nanopartices, and applications thereof |
| 12/17/2009 | US20090311331 Pellet Formulation Comprising Colloidal Silicon Dioxide |
| 12/17/2009 | US20090311330 Liquid oral compositions |
| 12/17/2009 | US20090311329 Casein micelles for nanoencapsulation of hydrophobic compounds |
| 12/17/2009 | US20090311328 Bulking of Soft Tissue |
| 12/17/2009 | US20090311327 Oral Therapeutic Compound Delivery System |
| 12/17/2009 | US20090311326 Pulmonary Insulin Crystals |
| 12/17/2009 | US20090311325 Enhancing solubility and dissolution rate of poorly soluble drugs |
| 12/17/2009 | US20090311324 Polymer matrix, method for its production, and its use |
| 12/17/2009 | US20090311323 Autologous somatic cells from peripheral blood and uses thereof |
| 12/17/2009 | US20090311322 Atorvastatin formulation |
| 12/17/2009 | US20090311321 Oral disintegrating tablet having masked bitter taste and method for production thereof |
| 12/17/2009 | US20090311320 Multilayer orally disintegrating tablet |
| 12/17/2009 | US20090311319 Oral Preparation With Controlled Release |
| 12/17/2009 | US20090311318 Substituted (s)-benzoxazinones |
| 12/17/2009 | US20090311317 Modified release tolterodine formulations |
| 12/17/2009 | US20090311316 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
| 12/17/2009 | US20090311315 Multimicroparticulate Oral Pharmaceutical Form with Modified Release of Angiotensin II Receptor Antagonists |
| 12/17/2009 | US20090311314 Tiotropium Containing Powder Formulation For Inhalation |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311312 Transdermal Hormone Delivery System: Compositions And Methods |
| 12/17/2009 | US20090311311 Transdermal local anesthetic patch with injection port |
| 12/17/2009 | US20090311310 Patch and patch preparation |
| 12/17/2009 | US20090311309 Novel Tissue Support |
| 12/17/2009 | US20090311308 Skincare compositions comprising salicyclic acid |
| 12/17/2009 | US20090311307 Hydractive Recipe |
| 12/17/2009 | US20090311297 Biocompatible Transparent Sheet, Method for Producing the Same, and Cultured Cell Sheet Used the Same Sheet |
| 12/17/2009 | US20090311296 Active Agent Delivery and/or Odor Retentive Composition and Methods of Use Thereof |
| 12/17/2009 | US20090311295 Particles with high uniform loading of nanoparticles and methods of preparation thereof |
| 12/17/2009 | US20090311292 Process for synthesis and incorporation of nitric oxide donors in macromolecular compositions |
| 12/17/2009 | US20090311291 Condoms with lubricant compositions and packaging providing enhanced functionality |
| 12/17/2009 | US20090311290 Urogenital or anorectal transmucosal vaccine delivery system |
| 12/17/2009 | US20090311231 Product and process for liquefaction of mucus or sputum |
| 12/17/2009 | US20090311230 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 12/17/2009 | US20090311197 Method and Compositions for Oral Hygiene |